Reshma Kewalramani
CEO & President, Director, Vertex Pharmaceuticals
Bought, 12 months
$0.0M
Sold, 12 months
$19.7M
Companies
1
Latest trade
Feb 27, 2026
Companies
Vertex PharmaceuticalsCEO & President, Director −$19.7M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.